Jacques Poupaert, Pascal Carato, Evelina Colacino, Saïd Yous
Unité de Chimie Pharmaceutique et Radiopharmacie, Ecole de Pharmacie, Université Catholique de Louvain, (UCL-CMFA 7340), Brussels B-1200, Belgium. poupaert@cmfa.ucl.ac.be
Current medicinal chemistry 2005The 2(3H)-benzoxazolone heterocycle and its bioisosteric surrogates (such as 2(3H)-benzothiazolinone, benzoxazinone, etc.) have received considerable attention from the medicinal chemists owing to their capacity to mimic a phenol or a catechol moiety in a metabolically stable template. These heterocycles and pyrocatechol have indeed similar pKa's, electronic charge distribution, and chemical reactivity. Therapeutic applications of this template are very broad, and range from analgesic anti-inflammatory compounds (including PPAR-gamma antagonists) to antipsychotic and neuroprotective anticonvulsant compounds. High affinity ligands have been obtained also for dopaminergic (D2 and D4), serotoninergic (5-HT1A and 5-HT-2A), sigma-1 and sigma-2 receptors. Owing to the high number of positive hits encountered with this heterocycle and its congeners, 2(3H)-benzoxazolone template certainly deserves the title of "privileged scaffold" in medicinal chemistry.
Jacques Poupaert, Pascal Carato, Evelina Colacino, Saïd Yous. 2(3H)-benzoxazolone and bioisosters as "privileged scaffold" in the design of pharmacological probes. Current medicinal chemistry. 2005;12(7):877-85
Mesh Tags
Substances
PMID: 15853716
View Full Text